Suppr超能文献

相似文献

1
Causal interpretation of the hazard ratio in randomized clinical trials.
Clin Trials. 2024 Oct;21(5):623-635. doi: 10.1177/17407745241243308. Epub 2024 Apr 28.
2
The built-in selection bias of hazard ratios formalized using structural causal models.
Lifetime Data Anal. 2024 Apr;30(2):404-438. doi: 10.1007/s10985-024-09617-y. Epub 2024 Feb 15.
3
Bias of the additive hazard model in the presence of causal effect heterogeneity.
Lifetime Data Anal. 2024 Apr;30(2):383-403. doi: 10.1007/s10985-024-09616-z. Epub 2024 Mar 11.
4
Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
Clin Trials. 2015 Jun;12(3):265-75. doi: 10.1177/1740774515572352. Epub 2015 Mar 1.
5
Single-world intervention graphs for defining, identifying, and communicating estimands in clinical trials.
Stat Med. 2023 Sep 20;42(21):3892-3902. doi: 10.1002/sim.9833. Epub 2023 Jun 21.
6
Translating questions to estimands in randomized clinical trials with intercurrent events.
Stat Med. 2022 Jul 20;41(16):3211-3228. doi: 10.1002/sim.9398. Epub 2022 May 16.
8
Treatment effect quantification for time-to-event endpoints-Estimands, analysis strategies, and beyond.
Pharm Stat. 2019 Mar;18(2):145-165. doi: 10.1002/pst.1917. Epub 2018 Nov 26.
9
Implementation of tripartite estimands using adherence causal estimators under the causal inference framework.
Pharm Stat. 2021 Jan;20(1):55-67. doi: 10.1002/pst.2054. Epub 2020 Aug 10.

引用本文的文献

1
Correcting for bias due to mismeasured exposure in mediation analysis with a survival outcome.
J R Stat Soc Ser C Appl Stat. 2025 Feb 14;74(4):969-993. doi: 10.1093/jrsssc/qlaf010. eCollection 2025 Nov.
2
Revisiting the hazards of hazard ratios through simulations and case studies.
Eur J Epidemiol. 2025 Jul 3. doi: 10.1007/s10654-025-01245-6.
3
A new method for dealing with collider bias in the PWP model for recurrent events in randomized controlled trials.
BMC Med Res Methodol. 2025 May 26;25(1):142. doi: 10.1186/s12874-025-02596-0.
5
Reply to Heitjan's commentary.
Clin Trials. 2024 Oct;21(5):638-639. doi: 10.1177/17407745241243311. Epub 2024 Apr 28.

本文引用的文献

1
Eliminating Ambiguous Treatment Effects Using Estimands.
Am J Epidemiol. 2023 Jun 2;192(6):987-994. doi: 10.1093/aje/kwad036.
2
A sensitivity analysis approach for the causal hazard ratio in randomized and observational studies.
Biometrics. 2023 Sep;79(3):2743-2756. doi: 10.1111/biom.13797. Epub 2022 Nov 29.
4
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.
N Engl J Med. 2021 Nov 4;385(19):1761-1773. doi: 10.1056/NEJMoa2110345. Epub 2021 Sep 15.
5
Propensity score weighting for covariate adjustment in randomized clinical trials.
Stat Med. 2021 Feb 20;40(4):842-858. doi: 10.1002/sim.8805. Epub 2020 Nov 10.
6
Survival analysis using a 5-step stratified testing and amalgamation routine (5-STAR) in randomized clinical trials.
Stat Med. 2020 Dec 30;39(30):4724-4744. doi: 10.1002/sim.8750. Epub 2020 Sep 20.
7
Subtleties in the interpretation of hazard contrasts.
Lifetime Data Anal. 2020 Oct;26(4):833-855. doi: 10.1007/s10985-020-09501-5. Epub 2020 Jul 11.
8
Analysis of covariance in randomized trials: More precision and valid confidence intervals, without model assumptions.
Biometrics. 2019 Dec;75(4):1391-1400. doi: 10.1111/biom.13062. Epub 2019 Jun 3.
9
Limitations of hazard ratios in clinical trials.
Eur Heart J. 2019 May 1;40(17):1378-1383. doi: 10.1093/eurheartj/ehy770.
10
Treatment effect quantification for time-to-event endpoints-Estimands, analysis strategies, and beyond.
Pharm Stat. 2019 Mar;18(2):145-165. doi: 10.1002/pst.1917. Epub 2018 Nov 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验